Company

ErythroSight

Biotechnology Research Australian Capital Territory, Au 2 employees

Employees: 2

www.clearvisionresearch.com LinkedIn

ErythroSight Overview

Headquarters: Australian Capital Territory, Au
Website: www.clearvisionresearch.com
Industry: Biotechnology Research
Employees: 2
Founded: 2023
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About ErythroSight

At ErythroSight (a spinout being incubated at ANU and Clear Vision Research), we are developing next-generation therapeutics for the treatment of retinal- and neuro-degenerations. Using Red Blood Cell Derived Extracellular Vesicles (RBC-EVs), we are developing a safe, inexpensive and personalised blood-derived product to treat Age-related Macular Degeneration (AMD), the number one cause of irreversible blindness in the developed world.

ErythroSight Contact Details

People in AeroLeads: 2

ErythroSight Org Chart

Sample employees and titles

Name	Title	Location	Contact
Adrian C.	Post-doctoral Fellow - Biotech	Canberra, Australian Capital Territory, Australia	View
Yvette Wooff	Medical Researcher - COO - Co-founder	Australia	View